IBDEI0VU ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14176,1,3,0)
 ;;=3^Cerebrovascular Disease,Apraxia,Unspec
 ;;^UTILITY(U,$J,358.3,14176,1,4,0)
 ;;=4^I69.990
 ;;^UTILITY(U,$J,358.3,14176,2)
 ;;=^5007568
 ;;^UTILITY(U,$J,358.3,14177,0)
 ;;=I69.993^^83^822^20
 ;;^UTILITY(U,$J,358.3,14177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14177,1,3,0)
 ;;=3^Cerebrovascular Disease,Ataxia,Unspec
 ;;^UTILITY(U,$J,358.3,14177,1,4,0)
 ;;=4^I69.993
 ;;^UTILITY(U,$J,358.3,14177,2)
 ;;=^5007571
 ;;^UTILITY(U,$J,358.3,14178,0)
 ;;=I69.922^^83^822^21
 ;;^UTILITY(U,$J,358.3,14178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14178,1,3,0)
 ;;=3^Cerebrovascular Disease,Dysarthria,Unspec
 ;;^UTILITY(U,$J,358.3,14178,1,4,0)
 ;;=4^I69.922
 ;;^UTILITY(U,$J,358.3,14178,2)
 ;;=^5007555
 ;;^UTILITY(U,$J,358.3,14179,0)
 ;;=I69.991^^83^822^22
 ;;^UTILITY(U,$J,358.3,14179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14179,1,3,0)
 ;;=3^Cerebrovascular Disease,Dysphagia
 ;;^UTILITY(U,$J,358.3,14179,1,4,0)
 ;;=4^I69.991
 ;;^UTILITY(U,$J,358.3,14179,2)
 ;;=^5007569
 ;;^UTILITY(U,$J,358.3,14180,0)
 ;;=I69.921^^83^822^23
 ;;^UTILITY(U,$J,358.3,14180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14180,1,3,0)
 ;;=3^Cerebrovascular Disease,Dysphasia
 ;;^UTILITY(U,$J,358.3,14180,1,4,0)
 ;;=4^I69.921
 ;;^UTILITY(U,$J,358.3,14180,2)
 ;;=^5007554
 ;;^UTILITY(U,$J,358.3,14181,0)
 ;;=I69.992^^83^822^24
 ;;^UTILITY(U,$J,358.3,14181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14181,1,3,0)
 ;;=3^Cerebrovascular Disease,Facial Weakness
 ;;^UTILITY(U,$J,358.3,14181,1,4,0)
 ;;=4^I69.992
 ;;^UTILITY(U,$J,358.3,14181,2)
 ;;=^5007570
 ;;^UTILITY(U,$J,358.3,14182,0)
 ;;=I69.923^^83^822^25
 ;;^UTILITY(U,$J,358.3,14182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14182,1,3,0)
 ;;=3^Cerebrovascular Disease,Fluency Disorder
 ;;^UTILITY(U,$J,358.3,14182,1,4,0)
 ;;=4^I69.923
 ;;^UTILITY(U,$J,358.3,14182,2)
 ;;=^5007556
 ;;^UTILITY(U,$J,358.3,14183,0)
 ;;=I69.952^^83^822^26
 ;;^UTILITY(U,$J,358.3,14183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14183,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Left Dominant Side
 ;;^UTILITY(U,$J,358.3,14183,1,4,0)
 ;;=4^I69.952
 ;;^UTILITY(U,$J,358.3,14183,2)
 ;;=^5133586
 ;;^UTILITY(U,$J,358.3,14184,0)
 ;;=I69.954^^83^822^27
 ;;^UTILITY(U,$J,358.3,14184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14184,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Left Nondominant Side
 ;;^UTILITY(U,$J,358.3,14184,1,4,0)
 ;;=4^I69.954
 ;;^UTILITY(U,$J,358.3,14184,2)
 ;;=^5133587
 ;;^UTILITY(U,$J,358.3,14185,0)
 ;;=I69.951^^83^822^28
 ;;^UTILITY(U,$J,358.3,14185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14185,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Right Dominant Side
 ;;^UTILITY(U,$J,358.3,14185,1,4,0)
 ;;=4^I69.951
 ;;^UTILITY(U,$J,358.3,14185,2)
 ;;=^5007561
 ;;^UTILITY(U,$J,358.3,14186,0)
 ;;=I69.953^^83^822^29
 ;;^UTILITY(U,$J,358.3,14186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14186,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Right Nondominant Side
 ;;^UTILITY(U,$J,358.3,14186,1,4,0)
 ;;=4^I69.953
 ;;^UTILITY(U,$J,358.3,14186,2)
 ;;=^5007562
 ;;^UTILITY(U,$J,358.3,14187,0)
 ;;=I69.942^^83^822^30
 ;;^UTILITY(U,$J,358.3,14187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14187,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Lower Dominant Side
